Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

BUY

Likes the financial sector. It’s been in a tight range. Found support around $22.50. There is good support at $20. Would be a buyer here.

BUY

Average down? Yes, enter it now. MFC trades at 7x earnings and yields over 4% and trades below book value, so it's now at a discount. Their wealth/asset management and Asian business are doing well.

BUY

Long term? He likes MFC, a mainstay for him. MFC has been through a trial over the past 12 months with a legal issue. He likes the 4.6% dividend, which matches the banks, something he was a doubtful about just recently. MFC isn't a bad way to collect yield. It has strong fundamentals. Good long term and he would add to it now. They are growing their dividend.

HOLD

It has been a bit of a disappointment in that it has Asian exposure and has been there for decades, but the yield curve is a real headwind. They have to keep taking charges. He prefers SLF-T. They are good, solid companies, but they need a break on the yield curve.

DON'T BUY

He recently sold it, because MFC broke a trend as interest rates fell and he saw better returns in REITs. MFC's equity division fluctuates with the economy. That said, very long term you can hold this for a long time. But there are better opportunities like the Brookfield REITs.

BUY

Stay in this one. A company you want to hold in a volatile market. Lower interest rates would make this company suffer and this is the fundamental problem for them right now. They need higher rates to fund their actuarial exposure. Buy it here and hold long term. Yield 4.9%

PAST TOP PICK

(A Top Pick Aug 09/18, Down 3%) One of the more diverse names in the insurance space. Exposure to US and Asia. Their results have been fine, and their last quarter was good. You can collect dividends while waiting for the company to get a footing.

DON'T BUY

During low interest rates Low rates are deadly for lifecos which are invested in fixed income and real estate. Don't invest in rate-sensitive stocks.

HOLD

MFC-T vs. Canadian Banks. He considers MFC-T to be a core holding. Low interest rates are a challenge for all financials. MFC-T is cleaning up some assets in the US. They are getting these assets under control. They are still growing in Asia. He thinks low interest rates are priced in to the stock price. (Analysts’ price target is $28.00)

BUY

He sees upside. A large part of the assets are bonds and prices have gone up lately. They are, however, suffering with low yields for new money. New insurance policies should get more expensive. It is a great long term hold and you have to accept the volatility. Things could get softer if rates go to zero.

COMMENT

Great Asian franchise. Problem is the US franchise John Hancock, which dragged down their ROE. Strong asset management in Canada. Nice dividend. Low interest rates not helping. Cleaned up balance sheet. Not paying a lot for the stock.

BUY ON WEAKNESS

They still have some litigation overhang though it's partially resolved. Their Q2 results were fine with minimal difference between core and reporting earnings--good. Book value per share is higher at $22.89, so the stock is trading right under this now. Asian earnings were up 15% year over year, which the market was worried about. The balance sheet is improving. He sees 8% EPS growth. Tt's trading at a very low 6.9x PE 2020. Very cheap with a good dividend. You can add a little on weakness in coming months.

COMMENT

Stuck in a trading range. Short sellers? Wouldn't have considered Manulife being a prime candidate for options selling. He blames interest rates. For insurance company to work, across the globe, you need higher interest rates. The other things is there has been some missteps in the past, did a big financing at the top, issued a lot of shares, they should look at buying back shares. Likes the exposure to China and India. Owns the stock, great company, and continues to hold it. 4% dividend yield.

PAST TOP PICK

(A Top Pick Jul 16/18, Up 7%) He still recommends it and the insurance space in general. It trades just over book value and has a yield of 4%. There is good growth in Asia and they have expanded into Euroasia as well. A well run company that has managed well since the 2008 crisis. One of his favorites.

BUY

A Canadian stalwart in insurance. It's much more sensitive to the equity markets than other financial stocks, so if the US cuts rates, MFC will be a little negative for Canadian banks, but a little positive for the insurers, including MFC. That lawsuit last Q4 knocked 10% off its market cap, though they wont that suit and MFC stock has since recovered.

Showing 361 to 375 of 2,279 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)